Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia

Sanne H. Tonino, Rene Spijker, Dieuwertje M.P. Luijks, Marinus H. J. van Oers, Arnon P. Kater

Blood (2008) 112 (3): 840–843.

https://doi.org/10.1182/blood-2008-03-144576

Published: 2008

Journal Articles

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Sanne H. Tonino, MD, Rene Spijker, Marinus H.J. Van Oers, MD, PhD, Arnon P. Kater, MD, PhD

Blood (2007) 110 (11): 1139.

https://doi.org/10.1182/blood.V110.11.1139.1139

Published: 2007

Journal Articles

Increased Expression Level of Noxa in Peripheral Versus Lymph Node Chronic Lymphocytic Leukemia Cells Is Correlated with Survival Capacity.

Delfine Y.H. Hallaert, Laura A. Smit, Rene Spijker, Bart de Goeij, Annelieke Jaspers, Arnon P. Kater, MD, PhD, Marinus H. van Oers, MD, PhD, Carel J.M. van Noesel, MD, PhD, Eric Eldering, PhD

Blood (2006) 108 (11): 4972.

https://doi.org/10.1182/blood.V108.11.4972.4972

Published: 2006

Journal Articles

Attacking Oncogene Addiction in B-CLL: Seliciclib First Engages the Mcl-1/Noxa Axis, after Which Gradual Exhaustion of Bcl-2 Protection Leads to Bax Activation.

Delfine Y.H. Hallaert, Rene Spijker, Margot Jak, Annelieke Jaspers, Ingrid A.M. Derks, Nuno L. Alves, Drs, Jan Paul de Boer, Daphne de Jong, MD, Simon R. Green, Rene A.W. van Lier, MD, PhD, Marinus H.J. van Oers, MD, PhD, Eric Eldering, PhD

Blood (2006) 108 (11): 2103.

https://doi.org/10.1182/blood.V108.11.2103.2103

Published: 2006

Journal Articles

The Novel Cancer Drug Seliciclib Engages the Mitochondrial Apoptosis Pathway Via the Mcl-1/Noxa Axis in CLL.

Delfine Hallaert, Rene Spijker, Ingrid A.M. Derks, Margot Jak, MD, Bart de Goeij, Jan Paul de Boer, MD, PhD, Daphne de Jong, MD, PhD, Simon R. Green, Rene van Lier, MD, PhD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2005) 106 (11): 2983.

https://doi.org/10.1182/blood.V106.11.2983.2983

Published: 2005

NARROW

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Increased Expression Level of Noxa in Peripheral Versus Lymph Node Chronic Lymphocytic Leukemia Cells Is Correlated with Survival Capacity.

Attacking Oncogene Addiction in B-CLL: Seliciclib First Engages the Mcl-1/Noxa Axis, after Which Gradual Exhaustion of Bcl-2 Protection Leads to Bax Activation.

The Novel Cancer Drug Seliciclib Engages the Mitochondrial Apoptosis Pathway Via the Mcl-1/Noxa Axis in CLL.

Email alerts

ASH Publications

American Society of Hematology

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia

CD31-CD38 Interaction Has No Major Role in the Pathogenesis of CLL.

Increased Expression Level of Noxa in Peripheral Versus Lymph Node Chronic Lymphocytic Leukemia Cells Is Correlated with Survival Capacity.

Attacking Oncogene Addiction in B-CLL: Seliciclib First Engages the Mcl-1/Noxa Axis, after Which Gradual Exhaustion of Bcl-2 Protection Leads to Bax Activation.

The Novel Cancer Drug Seliciclib Engages the Mitochondrial Apoptosis Pathway Via the Mcl-1/Noxa Axis in CLL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only